ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ackermans and Van Haaren NV

Ackermans and Van Haaren NV (B3K)

184.10
-12.20
(-6.21%)
Closed January 25 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
184.10
Bid
183.90
Ask
184.30
Volume
608
183.40 Day's Range 193.10
154.20 52 Week Range 197.50
Previous Close
196.30
Open
193.10
Last Trade
30
@
184.8
Last Trade Time
Average Volume (3m)
42
Financial Volume
-
VWAP
-

B3K Latest News

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros Dear shareholder, Dear Madam, Dear Sir, please find attached our press...

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros.

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros. Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint...

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda & Co

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda &...

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co Dear...

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint notre communiqué. Meilleures salutations...

Ackermans & van Haaren invests an additional 5 million euros in Biotalys

Ackermans & van Haaren invests an additional 5 million euros in Biotalys Dear shareholder, Dear Madam, Dear Sir, please find attached our press release. Best regards Ackermans & van Haaren...

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%) Dear shareholder, Dear Madam, Dear...

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%)

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%) Cher actionnaire...

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company Dear shareholder, Dear Madam, Dear Sir, please...

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge Cher actionnaire, Monsieur, Madame, veuillez...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-9-4.66079751424193.1196183.449194.77926829DE
4-3-1.60342063068187.1197.5183.443193.37296248DE
12-3.1-1.65598290598187.2197.5179.642188.99134871DE
2614.88.7418783225169.3197.5163.336184.78792433DE
5228.118.0128205128156197.5154.1999941173.03286368DE
15631.4000120.5632037042152.69999197.5136.341165.8623887DE
26031.4000120.5632037042152.69999197.5136.341165.8623887DE

B3K - Frequently Asked Questions (FAQ)

What is the current Ackermans and Van Haaren... share price?
The current share price of Ackermans and Van Haaren... is 184.10 €
What is the 1 year trading range for Ackermans and Van Haaren... share price?
Ackermans and Van Haaren... has traded in the range of 154.20 € to 197.50 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M

Discussion

View Full Feed
CanItBThisEZ2Make CanItBThisEZ2Make 3 minutes ago
Well the big money is in buying low and selling high. So I will chose to buy as much as possible as soon as possible. IMO - NFA

43 Hours to Go, I can't wait

GO $AZRH
AZRH
georgie18 georgie18 3 minutes ago
Your very welcome…🥳
MrGandol MrGandol 3 minutes ago
When is this : NASDAQ deal and is it real?
WPFH
Monksdream Monksdream 3 minutes ago
EXOD
https://investorshub.advfn.com/uimage/uploads/2025/1/25/bg[hjIMG_4826.gif
EXOD
tunnelvisionofplenty tunnelvisionofplenty 3 minutes ago
Nice, definitely encouraging to see. I was a little leery of drawing conclusions yet since EMA and MHRA approval don't necessarily go hand in hand (mRESVIA is a case in point – it's been approved in Europe since August, but is still pending in the UK). But then, in https://ir.telixpharma.com/news-r
NWBO
Penny2Dime Penny2Dime 5 minutes ago
Bottom fishing here!
MJNA
solidgold solidgold 5 minutes ago
So when tests are supposed to be ready?
NBRI
Monksdream Monksdream 6 minutes ago
BBAR
https://investorshub.advfn.com/uimage/uploads/2025/1/25/qautsIMG_4825.gif
BBAR
CanItBThisEZ2Make CanItBThisEZ2Make 6 minutes ago
OK, Well good for you and good for me when I suck up all the 2s and 3s again :)

GO SRMX(TCCI)$
SRMX
Tr8dervic Tr8dervic 6 minutes ago
Mega Million numbers for 01/24/2025 are:

08 12 43 52 62 Mega Ball 18
Megaplier is 2

There was no Jackpot Winner

The estimated Jackpot was $28.0 Million ( $12.4 Million cash).

The next drawing is on Tuesday, Jan 28, 2025 wit
Penny2Dime Penny2Dime 7 minutes ago
Correct!
MEDH
dcspka dcspka 8 minutes ago
As the white Boer farmers/overall investment structure continues to collapse into chaos in South Africa, eating dirt and rocks will become their main option.
TXTM
Gmenfan Gmenfan 8 minutes ago
Anyone have one of these magic black hats?

https://media.gettr.com/group5/getter/2025/01/25/17/45e14402-892d-a584-198d-0c430c55d1a6/67ec70bc073766938ce00da2f440aac8_768x0.png
Gmenfan Gmenfan 8 minutes ago
Anyone have one of these magic black hats?

https://media.gettr.com/group5/getter/2025/01/25/17/45e14402-892d-a584-198d-0c430c55d1a6/67ec70bc073766938ce00da2f440aac8_768x0.png
CanItBThisEZ2Make CanItBThisEZ2Make 9 minutes ago
OK, I'm looking at it and what do I see?
Does it say she still works for Tri Cascade?
https://investorshub.advfn.com/uimage/uploads/2025/1/25/mdqjuMASOUMI_MERNAZ_STILL_AT_TRI_CASCADE_QUESTION.jpg
GO SRMX(TCCI)$
SRMX
Juststoppingby Juststoppingby 9 minutes ago
From Mar 06, 2024, 8-K Share Exchange Agreement.

3.6. Financial Statements.

(a) The Company is in the process of preparing and providing to the Parent a copy of its unaudited consolidated financial statement for the fiscal period ended December 31, 2023 and, to
CRTG
BullNBear52 BullNBear52 10 minutes ago
So should Thom Tillis my senator.
Mufaso Mufaso 10 minutes ago
Fred- I think you are referring to my #msg-175662583 where I stated:
All in all I think the risk reward profile for many (including me) has changed. Still think it's a good long term investment but things have definitely changed of late and JPM talk by Brian put a spotlight on it which was a
JPM LLY NVO
Gmenfan Gmenfan 10 minutes ago
Same in my area Al and like in your area there are plenty of hunters.
HoldEm777 HoldEm777 10 minutes ago
Well I did a quick scan this morning and when I got to Alessi (Janbella) my mind was made up. A 1-A in filings. Very similar in structure to another we are familiar with. So I will move along as my opinion would not be welcomed. Good luck.
ASII
BullNBear52 BullNBear52 11 minutes ago
Any days you spend beyond the set length of stay is on them. In fairness they are not equipped or staffed for orthopedic rehab so you were in a better place than the hospital.

Heathsouth specialized in Ortho rehab and had a location a couple of blocks from the hospital.

Your Recent History

Delayed Upgrade Clock